文献速递眼底病与葡萄膜炎

微小RNA相关遗传变异与1型糖尿病患者的糖尿病视网膜病变相关

MicroRNA-Related Genetic Variants Are Associated With Diabetic Retinopathy in Type 1 Diabetes Mellitus.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2019-01-01

研究利用全基因组关联研究数据(n=325)推算微小RNA基因及结合位点的单核苷酸多态性,并在更大队列(N=560)中对排名靠前的SNP进行基因分型验证。结果显示MIR449b中的rs10061133与威胁视力的糖尿病视网膜病变(OR=0.32,P=3.68×10⁻⁴)和增殖性糖尿病视网膜病变(OR=0.30,P=8.12×10⁻⁴)风险降低相关,且随着队列扩大关联更显著。结论认为该变异与白人1型糖尿病患者增殖性及威胁视力糖尿病视网膜病变风险降低显著相关。

要点

  • 在MIR449b的rs10061133与威胁视力糖尿病视网膜病变风险降低相关(OR=0.32,P=3.68×10⁻⁴)。
  • rs10061133与增殖性糖尿病视网膜病变风险降低相关(OR=0.30,P=8.12×10⁻⁴)。
  • 随着队列样本量增加,上述关联变得更显著。

核心结论

  • MIR449b中的rs10061133与白人1型糖尿病患者增殖性糖尿病视网膜病变和威胁视力糖尿病视网膜病变风险降低显著相关。

研究设计与样本

  • 利用全基因组关联研究数据(n=325,包括糖尿病视网膜病变病例和糖尿病对照)推算已知SNP,使用miRNASNP和PolymiRTS(版本2)数据库提取相关SNP。
  • 采用χ²检验和逻辑回归(校正年龄、性别、糖尿病病程、HbA1c和高血压)检验推算SNP与糖尿病视网膜病变表型的关联。
  • 在更大队列(N=560)中对排名靠前的SNP进行基因分型以确认关联。

主要发现

  • 选择rs10061133、rs1049835、rs9501255三个SNP在最终队列中进行基因分型。
  • MIR449b中的rs10061133与威胁视力糖尿病视网膜病变风险降低相关(OR=0.32,P=3.68×10⁻⁴)。
  • rs10061133与增殖性糖尿病视网膜病变风险降低相关(OR=0.30,P=8.12×10⁻⁴)。
  • 随着队列样本量增加,上述关联变得更显著。

关键数值与推荐

  • 威胁视力糖尿病视网膜病变定义为增殖性糖尿病视网膜病变、重度非增殖性糖尿病视网膜病变或临床显著性黄斑水肿。
  • 关联分析比较糖尿病视网膜病变表型(任何糖尿病视网膜病变、非增殖性糖尿病视网膜病变、增殖性糖尿病视网膜病变、糖尿病黄斑水肿、威胁视力糖尿病视网膜病变)与糖尿病对照。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Few studies have explored the association of genetic variants in microRNA genes and binding sites with diabetic retinopathy (DR) in type 1 diabetes. We conducted a genome-wide scan for single nucleotide polymorphisms (SNPs) in these genes by using data from a genome-wide association study (GWAS). METHODS: All known SNPs were imputed from our GWAS data (n = 325) of DR cases and diabetic controls (no DR). Relevant SNPS were extracted using miRNASNP and PolymiRTS (version 2) databases. χ2 tests and logistic regression (adjusting for age, sex, duration of diabetes, HbA1c, and hypertension) were used to test the association between the imputed SNPs and DR phenotypes (any DR, nonproliferative DR [NPDR], proliferative DR [PDR], diabetic macular edema [DME], and sight-threatening DR defined as PDR, severe NPDR, or clinically significant macula edema [CSME]) compared with diabetic controls. Top-ranking SNPs were genotyped in a larger cohort (N = 560) to confirm their association with DR. RESULTS: Three SNPs (rs10061133, rs1049835, rs9501255) were selected and genotyped in the final cohort. Rs10061133 in MIR449b was protective of sight-threatening DR (odds ratio [OR] = 0.32, P = 3.68 × 10-4) and PDR (OR = 0.30, P = 8.12 × 10-4), and the associations became more significant as the cohort increased in size. CONCLUSIONS: Rs10061133 in MIR449b is significantly associated with a decreased risk of PDR and sight-threatening DR in Caucasian patients with type 1 diabetes. This can guide future studies on genetic risk profiling and on developing microRNA-related therapies for sight-threatening DR.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Liu E, Kaidonis G, McComish BJ, et al. MicroRNA-Related Genetic Variants Are Associated With Diabetic Retinopathy in Type 1 Diabetes Mellitus. Invest Ophthalmol Vis Sci. 2019. PMID: 31546259. doi:10.1167/iovs.18-25570

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。